Real-world outcomes of two-year Conbercept therapy for diabetic macular edema.

Cheng, Yong; Yuan, Li; Zhao, Ming-Wei; Qian, Tong

Cheng, Yong; Yuan, Li; Zhao, Ming-Wei; Qian, Tong.

Afiliación

Cheng Y; Department of Ophthalmology, People's Hospital, Peking University, Beijing 100044, China.
Yuan L; Eye Diseases and Optometry Institute, College of Optometry, Peking University Health Science Center, Beijing 100044, China.
Zhao MW; Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, Beijing 100044, China.
Qian T; Department of Ophthalmology, People's Hospital, Peking University, Beijing 100044, China.

Int J Ophthalmol ; 14(3): 416-422, 2021.

Article en En | MEDLINE | ID: mdl-33747819

Palabras clave

Conbercept; diabetic macular edema; intravitreal; visual acuity

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Int J Ophthalmol Año: 2021 Tipo del documento: Article País de afiliación: China